Literature DB >> 17198074

Markedly elevated serum CA 19-9 levels in association with a benign biliary stricture due to primary sclerosing cholangitis.

Mark D Murray1, Frank R Burton, Adrian M Di Bisceglie.   

Abstract

We report on the case of a 55-year-old man with long-standing ulcerative colitis who developed jaundice. This led to a diagnosis of primary sclerosing cholangitis being made, with a dominant stricture in the common bile duct. Serum CA 19-9 was initially markedly raised at 26,321 U/mL but fell promptly into the normal range after stenting of the stricture. Long-term follow up of this patient has failed to show evidence of cholangiocarcinoma. We conclude that serum CA 19-9 levels need to be assessed in the clinical context of biliary obstruction and should ideally be measured after relief of that obstruction, as it may be falsely elevated due to benign biliary strictures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17198074     DOI: 10.1097/MCG.0b013e31802dd094

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  10 in total

Review 1.  Focal intrahepatic strictures: a review of diagnosis and management.

Authors:  David Yeo; Marcos Vinicius Perini; Vijayaragavan Muralidharan; Christopher Christophi
Journal:  HPB (Oxford)       Date:  2012-07       Impact factor: 3.647

2.  Clinical implication of elevated CA 19-9 level and the relationship with glucose control state in patients with type 2 diabetes.

Authors:  Sun Hee Kim; Cho-Ok Baek; Kyung Ae Lee; Tae Sun Park; Hong Sun Baek; Heung Yong Jin
Journal:  Endocrine       Date:  2013-10-10       Impact factor: 3.633

3.  Markers of bile duct tumors.

Authors:  Giulia Malaguarnera; Maria Giordano; Isabella Paladina; Alessandra Rando; Mario Uccello; Francesco Basile; Antonio Biondi; Santo Carnazzo; Innocenza Alessandria; Clorinda Mazzarino
Journal:  World J Gastrointest Oncol       Date:  2011-04-15

4.  Type 2 diabetes mellitus and CA 19-9 levels.

Authors:  Oya Uygur-Bayramicli; Resat Dabak; Ekrem Orbay; Can Dolapcioglu; Mehmet Sargin; Gamze Kilicoglu; Yuksel Guleryuzlu; Alpaslan Mayadagli
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

5.  Increased serum levels of carbohydrate antigen 19-9 and outcomes in primary sclerosing cholangitis patients without cholangiocarcinoma.

Authors:  Preethi G K Venkatesh; Udayakumar Navaneethan; Bo Shen; Arthur J McCullough
Journal:  Dig Dis Sci       Date:  2012-09-25       Impact factor: 3.199

6.  Elevation of carbohydrate antigen 19.9 in benign hepatobiliary conditions and its correlation with serum bilirubin concentration.

Authors:  S L Ong; A Sachdeva; G Garcea; G Gravante; M S Metcalfe; D M Lloyd; D P Berry; A R Dennison
Journal:  Dig Dis Sci       Date:  2008-05-09       Impact factor: 3.199

7.  [CA19-9 in intrahepatic cholangiocarcinoma : A diagnostic and prognostic armamentarium?]

Authors:  B Juntermanns; G M Kaiser; S Itani Gutierrez; M Heuer; M Buechter; A Kahraman; H Reis; S Kasper; A Paul; C D Fingas
Journal:  Chirurg       Date:  2018-06       Impact factor: 0.955

8.  Tumor markers as a diagnostic key for hilar cholangiocarcinoma.

Authors:  B Juntermanns; S Radunz; M Heuer; S Hertel; H Reis; J P Neuhaus; S Vernadakis; T Trarbach; A Paul; Gernot M Kaiser
Journal:  Eur J Med Res       Date:  2010-08-20       Impact factor: 2.175

9.  Detection of benign hilar bile duct stenoses - A retrospective analysis in 250 patients with suspicion of Klatskin tumour.

Authors:  Uwe Scheuermann; Rizky Widyaningsih; Maria Hoppe-Lotichius; Michael Heise; Gerd Otto
Journal:  Ann Med Surg (Lond)       Date:  2016-05-10

10.  Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From Cholangiocarcinoma.

Authors:  Shunda Du; Gang Liu; Xinqi Cheng; Yue Li; Qian Wang; Ji Li; Xin Lu; Yongchang Zheng; Haifeng Xu; Tianyi Chi; Haitao Zhao; Yiyao Xu; Xinting Sang; Shouxian Zhong; Yilei Mao
Journal:  J Clin Gastroenterol       Date:  2016-07       Impact factor: 3.062

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.